Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexalin Technology (NXL) EBT Margin (2022 - 2025)

Historic EBT Margin for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to 12542.35%.

  • Nexalin Technology's EBT Margin fell 57470500.0% to 12542.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 5529.86%, marking a year-over-year decrease of 20998900.0%. This contributed to the annual value of 4511.61% for FY2024, which is 3140500.0% down from last year.
  • As of Q3 2025, Nexalin Technology's EBT Margin stood at 12542.35%, which was down 57470500.0% from 2239.74% recorded in Q2 2025.
  • Nexalin Technology's 5-year EBT Margin high stood at 55.68% for Q3 2022, and its period low was 12542.35% during Q3 2025.
  • In the last 4 years, Nexalin Technology's EBT Margin had a median value of 2449.0% in 2023 and averaged 4216.24%.
  • Per our database at Business Quant, Nexalin Technology's EBT Margin tumbled by -94710800bps in 2023 and then surged by 27314600bps in 2024.
  • Over the past 4 years, Nexalin Technology's EBT Margin (Quarter) stood at 1907.96% in 2022, then tumbled by -99bps to 3801.47% in 2023, then crashed by -174bps to 10425.24% in 2024, then decreased by -20bps to 12542.35% in 2025.
  • Its EBT Margin stands at 12542.35% for Q3 2025, versus 2239.74% for Q2 2025 and 4845.27% for Q1 2025.